Walmart cuts profit guidance as it sees slower growth due to inflation

Walmart cuts profit guidance as it sees slower growth due to inflation


Walmart on Monday cut its quarterly and full-year profit guidance, saying inflation was changing how its customers spend.

The big-box retailer said it now expects same-store sales to rise by about 6% in the second quarter, excluding fuel, as consumers buy more groceries instead of higher margin discretionary items.

Shares of the company fell about 7% after hours. It also dragged down other retailers’ stocks, including Target, which was down by more than 4%.

Read the full release here.

This is breaking news. Please check back for updates.



Source

Value is the key to McDonald’s growth plans, but it’s creating tensions with some franchisees
Business

Value is the key to McDonald’s growth plans, but it’s creating tensions with some franchisees

The restaurant sector has spent the past 18 months trying to figure out how to reach consumers in a hypercompetitive and uneven economy. McDonald’s, which is set to report earnings after the bell Wednesday, has doubled down on value messaging to customers via Extra Value Meals and Snack Wraps, which will likely help to boost […]

Read More
Kraft Heinz pauses work to split the company as new CEO says ‘challenges are fixable’
Business

Kraft Heinz pauses work to split the company as new CEO says ‘challenges are fixable’

Kraft Heinz in September 2025 announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Kraft Heinz on Wednesday said that it is pausing work on its previously announced plans to split the company. Shares […]

Read More
Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More